ATE404205T1 - Neue zusammenstellung von agomelatin und einem noradrenalin-wideraufnahme-hemmer und pharmazeutische zusammensetzungen, die sie enthalten - Google Patents

Neue zusammenstellung von agomelatin und einem noradrenalin-wideraufnahme-hemmer und pharmazeutische zusammensetzungen, die sie enthalten

Info

Publication number
ATE404205T1
ATE404205T1 AT06291421T AT06291421T ATE404205T1 AT E404205 T1 ATE404205 T1 AT E404205T1 AT 06291421 T AT06291421 T AT 06291421T AT 06291421 T AT06291421 T AT 06291421T AT E404205 T1 ATE404205 T1 AT E404205T1
Authority
AT
Austria
Prior art keywords
rupup
agomelatin
noradrenaline
inhibitor
pharmaceutical compositions
Prior art date
Application number
AT06291421T
Other languages
English (en)
Inventor
Elisabeth Mocaer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE404205T1 publication Critical patent/ATE404205T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06291421T 2005-09-09 2006-09-08 Neue zusammenstellung von agomelatin und einem noradrenalin-wideraufnahme-hemmer und pharmazeutische zusammensetzungen, die sie enthalten ATE404205T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509206A FR2890564B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
ATE404205T1 true ATE404205T1 (de) 2008-08-15

Family

ID=36190808

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06291421T ATE404205T1 (de) 2005-09-09 2006-09-08 Neue zusammenstellung von agomelatin und einem noradrenalin-wideraufnahme-hemmer und pharmazeutische zusammensetzungen, die sie enthalten

Country Status (39)

Country Link
US (1) US7622505B2 (de)
EP (1) EP1769798B1 (de)
JP (2) JP5395998B2 (de)
KR (1) KR100863384B1 (de)
CN (1) CN1927205A (de)
AP (1) AP2615A (de)
AR (1) AR056056A1 (de)
AT (1) ATE404205T1 (de)
AU (1) AU2006209368B2 (de)
BR (1) BRPI0603759A (de)
CA (1) CA2558782C (de)
CY (1) CY1108319T1 (de)
DE (1) DE602006002210D1 (de)
DK (1) DK1769798T3 (de)
EA (1) EA011650B1 (de)
ES (1) ES2313590T3 (de)
FR (1) FR2890564B1 (de)
GE (1) GEP20094742B (de)
GT (1) GT200600408A (de)
HR (1) HRP20080535T3 (de)
JO (1) JO2521B1 (de)
MA (1) MA28505B1 (de)
ME (2) ME02767B (de)
MX (1) MXPA06010157A (de)
MY (1) MY142260A (de)
NO (1) NO338029B1 (de)
NZ (1) NZ549725A (de)
PE (1) PE20070429A1 (de)
PL (1) PL1769798T3 (de)
PT (1) PT1769798E (de)
RS (1) RS50631B (de)
SA (1) SA06270308B1 (de)
SG (1) SG131030A1 (de)
SI (1) SI1769798T1 (de)
TW (1) TWI324513B (de)
UA (1) UA83542C2 (de)
UY (1) UY29778A1 (de)
WO (1) WO2007028904A1 (de)
ZA (1) ZA200607562B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4642134B2 (ja) * 2007-05-01 2011-03-02 コンサート ファーマシューティカルズ インコーポレイテッド ナフチル（エチル）アセトアミド
WO2008141033A1 (en) * 2007-05-08 2008-11-20 Auspex Pharmaceuticals Inc. Substituted naphthalenes
CN102342924A (zh) * 2010-08-05 2012-02-08 北京本草天源药物研究院 一种含有阿戈美拉汀的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
ZA989251B (en) * 1997-10-17 2000-04-10 Lilly Co Eli Potentiation of pharmaceuticals.
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
JP2005518439A (ja) * 2002-02-26 2005-06-23 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 抗痙攣性誘導体と抗片頭痛薬を含んで成る片頭痛治療用共治療薬
JP2004292445A (ja) * 2003-03-11 2004-10-21 Katsunori Nonogaki 糖尿病治療薬
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
BRPI0414347A (pt) * 2003-09-12 2006-11-07 Warner Lambert Co associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade

Also Published As

Publication number Publication date
AR056056A1 (es) 2007-09-12
CA2558782C (fr) 2012-05-15
GEP20094742B (en) 2009-07-27
NZ549725A (en) 2008-03-28
UY29778A1 (es) 2006-10-31
CA2558782A1 (fr) 2007-03-09
CN1927205A (zh) 2007-03-14
NO338029B1 (no) 2016-07-25
KR100863384B1 (ko) 2008-10-13
ME02758B (de) 2010-06-30
RS50631B (sr) 2010-06-30
JO2521B1 (en) 2010-03-17
TWI324513B (en) 2010-05-11
SI1769798T1 (sl) 2008-12-31
ME02767B (de) 2010-06-30
MY142260A (en) 2010-11-15
PL1769798T3 (pl) 2008-12-31
NO20064048L (no) 2007-03-12
AP2615A (en) 2013-03-14
WO2007028904A1 (fr) 2007-03-15
MXPA06010157A (es) 2007-03-08
ZA200607562B (en) 2008-05-28
AU2006209368B2 (en) 2012-07-19
EA011650B1 (ru) 2009-04-28
BRPI0603759A (pt) 2007-05-15
FR2890564A1 (fr) 2007-03-16
US20070060654A1 (en) 2007-03-15
CY1108319T1 (el) 2014-02-12
AP2008004378A0 (en) 2008-04-30
DE602006002210D1 (de) 2008-09-25
AU2006209368A1 (en) 2007-03-29
JP2007077147A (ja) 2007-03-29
JP5395998B2 (ja) 2014-01-22
TW200744570A (en) 2007-12-16
EA200601410A1 (ru) 2007-04-27
EP1769798B1 (de) 2008-08-13
FR2890564B1 (fr) 2007-10-19
ES2313590T3 (es) 2009-03-01
KR20070029606A (ko) 2007-03-14
PE20070429A1 (es) 2007-06-02
PT1769798E (pt) 2008-09-18
MA28505B1 (fr) 2007-04-03
SG131030A1 (en) 2007-04-26
EP1769798A1 (de) 2007-04-04
JP2011088919A (ja) 2011-05-06
UA83542C2 (uk) 2008-07-25
US7622505B2 (en) 2009-11-24
GT200600408A (es) 2007-05-21
HRP20080535T3 (en) 2008-12-31
DK1769798T3 (da) 2008-11-24
SA06270308B1 (ar) 2011-10-08

Similar Documents

Publication Publication Date Title
DE602005005456D1 (de) Neue azabicyclische derivate, herstellungsverfahren dafür und sie enthaltende pharmazeutische zusammensetzungen
DK1909764T3 (da) Farmaceutisk sammensætninger omfattende levetiracetam og fremgangsmåde til deres fremstilling
DK1884242T3 (da) Farmaceutisk sammensætning omfattende lurasidon
DK2063868T3 (da) Farmaceutiske sammensætninger indeholdende rosuvastatin-calcium
CL2007001325A1 (es) Compuestos derivados de biciclos, inhibidores de cept; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar hiperlipidemia, arterioesclerosis, entre otras enfermedades.
IL187997A0 (en) Indane derivatives and pharmaceutical compositions containing the same
IL188494A0 (en) Novel 2,4-dianlinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
IL186665A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
NO20092104L (no) Nye 1,2-dihydroquinolinderivater, farmasøytisk sammensetning inneholdende slike, samt anvendelse derav
IL180112A0 (en) Condensed benzamide compounds and pharmaceutical compositions containing the same
IL189782A (en) The history of sulfonylpyrol and its medicinal products and their use
IL208497A0 (en) Pharmaceutical compositions containing erythropoietin and derivatives thereof
EP1890677A4 (de) Pharmazeutische zusammensetzungen und ihre verwendung
IL187534A0 (en) Thiazole derivatives, use thereof and pharmaceutical compositions containing them
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2007003841A1 (es) Compuestos derivados de 4(5h-1 lambda-tiazol-2-il)piperidina; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar diabetes.
BRPI0620345A2 (pt) composto, composição farmacêutica, uso de um composto, e, métodod para o tratamento de uma doença
IL179530A0 (en) Novel compounds, pharmaceutical compositions containing same and methods of use for same
EP1723970A4 (de) Medizinische zusammensetzung mit cxcr3-hemmer
MA28603B1 (fr) Composition pharmaceutique antimycobacterienne
ATE409470T1 (de) Pharmazeutische zusammensetzungen mit malonamid- derivaten zur verringerung der talg-produktion
ATE404205T1 (de) Neue zusammenstellung von agomelatin und einem noradrenalin-wideraufnahme-hemmer und pharmazeutische zusammensetzungen, die sie enthalten
NO20052414L (no) Nye pyrrolidin- og tiazolidinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
AP2006003858A0 (en) New association of a sinus node if inhibitor and acalcium inhibitor, and pharmaceutical composition s containing it
ATE443512T1 (de) Pharmazeutische zusammensetzung von piperazinderivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1769798

Country of ref document: EP